share_log

Shandong Sino-Agri United Biotechnology Co.,Ltd's (SZSE:003042) Biggest Owners Are Individual Investors Who Got Richer After Stock Soared 25% Last Week

Shandong Sino-Agri United Biotechnology Co.,Ltd's (SZSE:003042) Biggest Owners Are Individual Investors Who Got Richer After Stock Soared 25% Last Week

山東新農聯合生物技術有限公司(深圳證券交易所:003042)最大的股東是個人投資者,他們在上週股票上漲25%後變得更加富有。
Simply Wall St ·  11/30 06:57

Key Insights

主要見解

  • Shandong Sino-Agri United BiotechnologyLtd's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
  • 51% of the business is held by the top 4 shareholders
  • Insider ownership in Shandong Sino-Agri United BiotechnologyLtd is 14%
  • 山東中農聯合生物技術有限公司的重要個人投資者所有權表明,關鍵決策受到大型公衆股東的影響。
  • 前4大股東持有51%的業務股份
  • 山東中農聯合生物技術有限公司的內部持股比例爲14%。

If you want to know who really controls Shandong Sino-Agri United Biotechnology Co.,Ltd (SZSE:003042), then you'll have to look at the makeup of its share registry. We can see that individual investors own the lion's share in the company with 41% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

如果你想知道誰真正控制山東中農聯合生物技術有限公司(深證:003042),那麼你需要查看其股份登記的構成。我們可以看到,個人投資者在公司中擁有41%的股份。因此,這個群體在投資該公司的過程中可能獲得最大收益(或承擔最大損失)。

As a result, individual investors collectively scored the highest last week as the company hit CN¥2.6b market cap following a 25% gain in the stock.

因此,個人投資者在上週集體獲勝,因爲公司在股票上漲25%後市值達到了26億人民幣。

Let's take a closer look to see what the different types of shareholders can tell us about Shandong Sino-Agri United BiotechnologyLtd.

讓我們仔細看看不同類型的股東能告訴我們關於山東省聯合生物技術有限公司的哪些信息。

big
SZSE:003042 Ownership Breakdown November 29th 2024
SZSE:003042 2024年11月29日的持股結構

What Does The Institutional Ownership Tell Us About Shandong Sino-Agri United BiotechnologyLtd?

機構持股告訴我們關於山東省聯合生物技術有限公司什麼?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見的指數回報進行比較。因此,他們通常會考慮購買包括在相關基準指數中的較大公司。

We can see that Shandong Sino-Agri United BiotechnologyLtd does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Shandong Sino-Agri United BiotechnologyLtd's earnings history below. Of course, the future is what really matters.

我們可以看到山東省聯合生物技術有限公司確實有機構投資者;並且他們持有公司相當一部分的股票。這可以表明公司在投資社區中具有一定的信譽。然而,最好小心依賴機構投資者所帶來的所謂驗證。他們有時也會犯錯。如果多個機構同時對某隻股票改變看法,你可能會看到股價迅速下跌。因此,值得查看山東省聯合生物技術有限公司的盈利歷史。當然,未來才是最重要的。

big
SZSE:003042 Earnings and Revenue Growth November 29th 2024
深交所:003042 2024年11月29日的盈利和收入增長

Hedge funds don't have many shares in Shandong Sino-Agri United BiotechnologyLtd. Looking at our data, we can see that the largest shareholder is Cnampgc Shanghai Corporation with 31% of shares outstanding. For context, the second largest shareholder holds about 9.6% of the shares outstanding, followed by an ownership of 8.6% by the third-largest shareholder. Hui Xu, who is the second-largest shareholder, also happens to hold the title of Chief Executive Officer.

對沖基金在山東省中農集團生物技術有限公司的股份不多。根據我們的數據,最大股東是上海泛海控股集團,持有31%的流通股份。爲了提供背景,第二大股東約持有9.6%的流通股份,第三大股東則持有8.6%的股份。第二大股東惠旭同時也是首席執行官。

To make our study more interesting, we found that the top 4 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.

爲了使我們的研究更有趣,我們發現前四名股東控制了公司一半以上的股份,這意味着該集團對公司的決策具有相當大的影響力。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.

研究公司的機構所有權可以爲您的研究增加價值,但同時調查分析師建議也是很好的做法,以更深入地了解股票的預期表現。我們目前沒有發現任何關於該公司的分析師報道,因此該公司不太可能被廣泛持有。

Insider Ownership Of Shandong Sino-Agri United BiotechnologyLtd

山東省中農集團生物技術有限公司的內部股東

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

公司內部人員的定義可能是主觀的,並在不同的司法管轄區之間有所不同。我們的數據反映了個人內部人員,至少包括董事會成員。管理層最終向董事會負責。然而,經理們成爲執行董事會成員並不罕見,尤其是如果他們是創始人或首席執行官。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部人士持股是一件好事。但是,在某些情況下,它會使其他股東更難以對董事會的決定進行問責。

Our most recent data indicates that insiders own a reasonable proportion of Shandong Sino-Agri United Biotechnology Co.,Ltd. Insiders own CN¥362m worth of shares in the CN¥2.6b company. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

我們的最新數據表明,內部人士擁有山東中農聯合生物技術有限公司合理比例的股份。內部人士擁有價值36200萬人民幣的股份,而公司市值爲26億人民幣。這可能表明創始人仍然擁有大量股份。您可以點擊此處查看他們是否有買入或賣出。

General Public Ownership

一般大衆所有權

With a 41% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Shandong Sino-Agri United BiotechnologyLtd. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

公衆持股佔41%,大部分爲個人投資者,他們在山東中農聯合生物技術有限公司中擁有一定的影響力。儘管這樣的持股規模可能不足以在政策決策中影響他們的利益,但他們仍然能對公司政策產生集體影響。

Private Company Ownership

私有公司的所有權

It seems that Private Companies own 40%, of the Shandong Sino-Agri United BiotechnologyLtd stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

看起來山東中農匯聯合生物技術有限公司的股票中,私營公司擁有40%的股份。這可能值得深入研究。如果相關方,如內部人士,對這些私人公司有興趣,那麼在年度報告中應該披露此信息。私營公司也可能對該公司具有戰略利益。

Next Steps:

下一步:

It's always worth thinking about the different groups who own shares in a company. But to understand Shandong Sino-Agri United BiotechnologyLtd better, we need to consider many other factors. Be aware that Shandong Sino-Agri United BiotechnologyLtd is showing 2 warning signs in our investment analysis , you should know about...

考慮到擁有公司股票的不同群體,總是很重要的。但要更好地了解山東中農匯聯合生物技術有限公司,我們需要考慮許多其他因素。請注意,山東中農匯聯合生物技術有限公司在我們的投資分析中顯示出了兩個警告信號,你應該知道...

Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.

當然,這可能不是最好的購買股票。因此,查看這份免費免費的有趣公司列表可能會有所幫助。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論